TMS: Matters relating to business plans and growth potential
TMS: Notice of participation in the “2024 Jeffries Global Healthcare Conference”
TMS: Notice regarding the development of TMS-008
TMS: Notice Concerning SMTP Compound Related Patents (Japan)
TMS: Announcement of the release of transcribed articles and videos of the financial results briefing for the fiscal year ending 2024/2
TMS: Presentation Material for the Fiscal Year Ended February 29,2024
TMS: Non-consolidated Financial Results for the Fiscal Year Ended February 29, 2024 [Japanese GAAP]
Timms: Announcement of publication of a transcript of the “IR Seminar for Individual Investors” hosted by Logme Finance
Tims: Notice of submission of a clinical trial plan notification form for the domestic phase 1 clinical trial of TMS-008
Tims: TMS submits clinical trial plan notification for TMS-008 phase I clinical trial in Japan
Tims: Notice of conclusion of license agreement relating to JX09
TMS: JIXING Announced the First Subject Dosing of JX09 Phase I Clinical Trial
TMS: JIXING completes administration of the first phase 1 clinical trial of JX09
TMS: Announcement of speakers at the “IR Seminar for Individual Investors” hosted by Logme Finance
TMS: Stock Transfer Report Affirmations Related to Third-Party Allocation (New Shares)
TMS: Stock Transfer Report Affirmations Related to Third-Party Allocation (New Shares)
TMS: Stock Transfer Report Affirmations Related to Third-Party Allocation (New Shares)
TMS: [Delayed]Non-consolidated Financial Results for the Nine Months Ended November 30, 2023 [Japanese GAAP]
TMS: [Delayed]Notice of Strategic Alliance between TMS and JIXING
TMS: Announcement of video distribution regarding capital and business alliances with JIXING and RTW
No Data